Search - tctmd.com

Displaying 501 - 520 of 1125

Sort: Relevancy | Date

Presentation TCT 2019

Optimal Timing for Surveillance Imaging After LAAC

Presenter: Saibal Kar

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Presentation TCT 2019

LAAO: Complications and Tips to Avoid Them With Case EGS

Presenter: Rajasekhar Varada

September 27, 2019

Presentation TCT 2019

Case #6: I Used OCT in This Calcified ISR

Presenter: Peep Laanmets

September 26, 2019

Presentation TCT 2019

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

Presentation TCT 2019

LAA Closure in Patients With Prior Intracranial Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Presentation TCT 2019

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Presenter: Edip Gurol

September 26, 2019

Presentation TCT 2019

TCT 120: Utilization of Percutaneous Thrombectomy in Patients with Massive and Very High-risk Submassive Acute Pulmonary Embolism

Presenter: Catalin Toma

September 25, 2019

Presentation TCT 2019

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

Presenter: William Gray

September 25, 2019

Presentation TCT 2019

TCT 119: Reduced Mortality in Severe PE with Ultrasound-Assisted Catheter-Directed Thrombolysis: A Single Center Experience.

Presenter: Shayan Nabavi Nouri

September 25, 2019

Presentation TCT 2019

TCT 118: Balloon pulmonary angioplasty for segmental and sub segmental thromboembolic lesions in patients with chronic thromboembolic pulmonary hypertension

Presenter: Vladimir Losev

September 25, 2019

Presentation TCT 2019

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Presenter: Stanislaw Jankiewicz

September 25, 2019

Advertisement

Optimal Timing for Surveillance Imaging After LAAC

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

LAAO: Complications and Tips to Avoid Them With Case EGS

Case #6: I Used OCT in This Calcified ISR

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

LAA Closure in Patients With Prior Intracranial Hemorrhage

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure in the United States: Update From the NCDR LAAO Registry

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

TCT 120: Utilization of Percutaneous Thrombectomy in Patients with Massive and Very High-risk Submassive Acute Pulmonary Embolism

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

TCT 119: Reduced Mortality in Severe PE with Ultrasound-Assisted Catheter-Directed Thrombolysis: A Single Center Experience.

TCT 118: Balloon pulmonary angioplasty for segmental and sub segmental thromboembolic lesions in patients with chronic thromboembolic pulmonary hypertension

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content